This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Normal University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Yiying Zeng: Innovator in Biomimetic Liposome Technology
Introduction
Yiying Zeng is a prominent inventor based in Hangzhou, China. She has made significant contributions to the field of biomimetic liposome technology. Her innovative work focuses on the development of dual-targeting liposomes that incorporate therapeutic agents for enhanced efficacy.
Latest Patents
Yiying Zeng holds a patent for a "Dual-targeting biomimetic liposome with elemene (ELE) and cabazitaxel (CTX), and preparation method and use thereof." This patent describes a formulation where each 100 mL of the dual-targeting biomimetic liposome includes 0.15 g to 0.75 g of ELE, 0.5 mL to 2.5 mL of absolute ethanol, 0.015 g to 0.07 g of CTX, and various other components. The innovative design aims to improve the delivery of cancer therapeutics.
Career Highlights
Yiying Zeng is affiliated with Hangzhou Normal University, where she conducts her research and development activities. Her work has garnered attention for its potential applications in cancer treatment. She has successfully developed a unique formulation that could lead to more effective therapeutic strategies.
Collaborations
Yiying collaborates with notable colleagues, including Tian Xie and Zhaowu Zeng. Their combined expertise contributes to the advancement of research in biomimetic technologies.
Conclusion
Yiying Zeng is a trailblazer in the field of biomimetic liposome technology, with a focus on innovative cancer therapies. Her contributions are paving the way for future advancements in medical treatments.